Viatris Return on Investment 2010-2025 | VTRS

Current and historical return on investment (ROI) values for Viatris (VTRS) over the last 10 years.
Viatris ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-03-31 $-3.08B $31.67B -8.90%
2024-12-31 $0.01B $34.61B 0.03%
2024-09-30 $-0.26B $35.97B -0.72%
2024-06-30 $-0.04B $36.05B -0.10%
2024-03-31 $0.57B $37.91B 1.48%
2023-12-31 $0.77B $36.66B 1.96%
2023-09-30 $1.02B $39.59B 2.56%
2023-06-30 $1.13B $39.76B 2.83%
2023-03-31 $1.31B $40.72B 3.26%
2022-12-31 $1.62B $39.09B 4.02%
2022-09-30 $1.74B $39.65B 4.30%
2022-06-30 $1.54B $40.83B 3.72%
2022-03-31 $0.94B $41.10B 2.23%
2021-12-31 $-0.03B $40.21B -0.08%
2021-09-30 $-0.84B $43.05B -1.85%
2021-06-30 $-0.84B $44.37B -2.10%
2021-03-31 $-0.66B $45.99B -1.92%
2020-12-31 $-0.21B $47.87B -0.73%
2020-09-30 $0.94B $22.55B 4.11%
2020-06-30 $0.92B $21.64B 3.90%
2020-03-31 $0.88B $23.38B 3.58%
2019-12-31 $0.72B $24.06B 2.85%
2019-09-30 $0.68B $24.85B 2.66%
2019-06-30 $0.69B $25.62B 2.67%
2019-03-31 $0.77B $26.11B 2.96%
2018-12-31 $0.91B $25.33B 3.45%
2018-09-30 $1.09B $26.51B 4.07%
2018-06-30 $1.07B $26.58B 3.97%
2018-03-31 $1.37B $26.76B 4.98%
2017-12-31 $1.44B $27.41B 5.20%
2017-09-30 $1.33B $27.28B 4.80%
2017-06-30 $0.88B $28.23B 3.26%
2017-03-31 $0.82B $27.73B 3.18%
2016-12-31 $0.70B $27.68B 2.99%
2016-09-30 $0.81B $24.80B 3.96%
2016-06-30 $1.54B $23.10B 8.32%
2016-03-31 $1.41B $17.94B 8.30%
2015-12-31 $1.46B $16.06B 8.84%
2015-09-30 $1.43B $17.02B 9.47%
2015-06-30 $1.32B $16.84B 9.85%
2015-03-31 $1.27B $16.22B 10.28%
2014-12-31 $1.35B $10.31B 11.89%
2014-09-30 $1.23B $10.40B 10.49%
2014-06-30 $1.08B $12.57B 9.24%
2014-03-31 $1.16B $12.24B 10.63%
2013-12-31 $1.14B $11.82B 11.14%
2013-09-30 $1.13B $10.04B 11.72%
2013-06-30 $1.12B $9.61B 12.04%
2013-03-31 $1.07B $9.34B 11.80%
2012-12-31 $1.11B $9.46B 12.29%
2012-09-30 $1.09B $8.83B 12.37%
2012-06-30 $1.03B $8.75B 11.76%
2012-03-31 $1.04B $9.07B 11.87%
2011-12-31 $1.01B $8.73B 11.44%
2011-09-30 $0.85B $8.32B 9.56%
2011-06-30 $0.82B $9.06B 8.97%
2011-03-31 $0.74B $9.04B 8.17%
2010-12-31 $0.72B $9.25B 8.10%
2010-09-30 $0.69B $9.22B 7.85%
2010-06-30 $0.52B $8.49B 5.98%
2010-03-31 $0.50B $8.72B 5.78%
2009-12-31 $0.52B $8.62B 6.24%
Sector Industry Market Cap Revenue
Medical Medical Services $9.730B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $132.070B 24.77
Elevance Health (ELV) United States $84.109B 10.85
CVS Health (CVS) United States $76.951B 9.56
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $22.591B 34.29
Natera (NTRA) United States $20.935B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.529B 0.00
Solventum (SOLV) United States $12.251B 12.97
CochLear (CHEOY) Australia $11.298B 0.00
Revvity (RVTY) United States $10.529B 18.12
ICON (ICLR) Ireland $10.336B 9.61
Doximity (DOCS) United States $9.525B 44.37
Avantor (AVTR) United States $8.647B 12.56
HealthEquity (HQY) United States $8.564B 42.13
Medpace Holdings (MEDP) United States $8.476B 22.51
Sonic Healthcare (SKHHY) Australia $8.176B 0.00
Charles River Laboratories (CRL) United States $6.716B 13.16
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.048B 37.47
Bausch + Lomb (BLCO) Canada $3.990B 23.52
Sotera Health (SHC) United States $3.452B 19.61
Surgery Partners (SGRY) United States $2.922B 38.00
Alignment Healthcare (ALHC) United States $2.865B 0.00
Concentras Parent (CON) United States $2.710B 15.66
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.091B 8.91
GeneDx Holdings (WGS) United States $2.043B 78.68
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.759B 38.72
PACS (PACS) United States $1.497B 0.00
GoodRx Holdings (GDRX) United States $1.336B 26.71
Teladoc Health (TDOC) United States $1.195B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Establishment Labs Holdings (ESTA) $1.059B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.944B 14.74
Agilon Health (AGL) United States $0.919B 0.00
Nutex Health (NUTX) United States $0.890B 13.45
AMN Healthcare Services Inc (AMN) United States $0.795B 7.44
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.626B 4.22
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.524B 0.00
Enhabit (EHAB) United States $0.518B 42.58
Auna S.A (AUNA) Luxembourg $0.492B 11.08
SBC Medicals (SBC) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.462B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.405B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
Performant Healthcare (PHLT) United States $0.215B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.096B 0.00
So-Young (SY) China $0.087B 0.00
Sera Prognostics (SERA) United States $0.066B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00